Two-year outcomes of hemi-Descemet membrane endothelial keratoplasty (hemi-DMEK)
My Session Status
Authors:Yelin Yang, Fargol Mostofian, Javiera
Compan, Kashif Baig
Author Disclosure Block: Y. Yang: None. F.
Mostofian: None. J. Compan: None. K. Baig: None.
Abstract Body:
Purpose: Hemi-Descemet Membrane Endothelial Keratoplasty
(hemi-DMEK) has been described as a technique to increase the availability of
donor cornea by splitting donor corneal transplant into two separate grafts.
The purpose of this study is to evaluate the long-term outcome after Hemi-DMEK
at a single tertiary center.
Study Design: Retrospective, observational case series
Methods: This is a case series of six eyes undergoing hemi-circle
shaped DMEK grafts at the University of Ottawa Eye Institute. Hemi-circle
grafts were created by equally dividing an 11.0 mm manually trephined graft.
The patient’s best-corrected visual acuity (BCVA) and endothelial cell density
(ECD) were evaluated up to 27 months postoperatively. Intraoperative and
postoperative complications were also assessed.
Results: The median age of patient was 78 years, with follow up
ranging from 18 to 27 months. Hemi-DMEK was successful in 5 out of 6 eyes; one
eye had persistent graft detachment and corneal edema despite re-bubbling. The
patient underwent repeat DMEK at 2 months postoperatively. All 5 successful
grafts cleared within 6 months, and had BVCA greater than 20/40 at the latest
follow up (range 18 to 27 months). Compared to preoperative measurements,
average central ECD decreased by 58% (range: 0.5% to 85% decrease) at final
follow up.
Conclusions: This case series highlights that hemi-DMEK is a
feasible method to increase availability of donor cornea with stable visual
outcomes up to two years.